2.7. Outcome Measures
Parkinson’s Disease Assessment Scale-III, Anxiety, anxiety
CORTEX
Volunteers will attend both conditions (synchronous and asynchronous remote video-based) in a randomized order, separated by a washing-out period of at least a week. Kinematic, DLPFC hemodynamic activity and levels of anxiety data will be collected before (base-line data) and after the two interventions, while, on a third occasion, control data will be collected at the same time points but without any intervention.Two experienced evaluators blinded to the group allocation will collect data. Baseline data collection will include: (1) Anthropometric characteristics (sex, age, body mass index), H&Y scale; (2) Anxiety Hamilton Rating Scale (Hamilton 1960); (3) Gait analysis using a 10-camera 3D motion analysis system (Vicon T-series, Oxford, UK) and two force platforms (Bertec 4060–10, OH) embedded in the laboratory floor; (4) Frontal cortex hemodynamic responses using f-NIRS (Portalite by Artinis NL); and (5) Unified Parkinson’s Disease Assessment Scale-III (UPDRS-III). Post intervention measurements will include: (1) Anxiety Hamilton Rating Scale (Hamilton 1960); (2) Gait analysis using a 10-camera 3D motion analysis system (Vicon T-series, Oxford, UK) and two force platforms (Bertec 4060–10, OH) embedded in the laboratory floor; (3) Frontal cortex hemodynamic responses using f-NIRS (Portalite by Artinis NL); and (4) Unified Parkinson’s Disease Assessment Scale-III (UPDRS-III).